Wikipedia -WSS

Wikipedia

author：leisure time 2025-09-30 17:05:04 - browse：2586

An AstraZeneca sign at ESMO in Madrid. — An AstraZeneca ad at ESMO 2023 in Madrid. Andrew Joseph/STAT

MADRID — Questions about one of AstraZeneca’s key cancer drug candidates — and the dribs and drabs that have come out about its performance — have been dogging the company for months.

On Monday, data presented here from a trial of the drug in advanced non-small cell lung cancer provided at least a fuller look. While the results assuaged some of the safety fears that flared when initial information was released over the summer, they only heightened concerns about the drug’s ability to outperform standard chemotherapy — though they perhaps pointed to an opportunity for the drug in a subset of patients.

The trial, detailed here in a prime session at the annual meeting of the European Society for Medical Oncology, is testing a therapy called datopotamab deruxtecan, or Dato-DXd, in advanced or metastatic non-small cell lung cancer in patients who already tried at least first-line treatments. Patients were randomized to either receive chemotherapy or Dato-DXd, which AstraZeneca is developing with Daiichi Sankyo.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Printout prescription drug information shouldn’t go digital

WSS

The Sacklers, horror, and ‘The Fall of the House of Usher’

FDA endorses new sterilization method for medical devices

Sanofi CEO defends move to abandon profit guidance, boost research

UCSF medical school apologizes for unethical prisoner experiments

Pumping milk in bathrooms at health conferences is common

TikTok, Instagram influencers need more rules for drug ads

hotspot

Wikipedia

knowledge

Bright Health sells Medicare Advantage business to Molina

Update the Apgar Score to remove skin color

Wildfire smoke exposes gaps in outdoor worker protections

Flu vaccine reformulation won't be easy, manufacturers warn

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Medicare will require more price transparency from hospitals

Hepatitis C has a cure — but many Americans still lack access to it

Pumping milk in bathrooms at health conferences is common

Malaria cases in Florida and Texas: Here’s what you need to know

Medicare solvency divides Republicans at the presidential debate

entertainment

HPV vaccine, cervical cancer study delivers historic results

Sanofi CEO defends move to abandon profit guidance, boost research

Immunocompromised patients offer clues on chronic Covid

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

Will General Catalyst be the first of many hospital takeovers?

Ambulance rides for just $100? Advisers want major billing fixes

explore

hotspot

knowledge

hotspot